Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
22,678
22,873
21,833
21,067
21,532
37,520
Crecimiento de los Ingresos (YoY)
4%
5%
4%
-2%
-43%
3%
Costo de los ingresos
16,995
17,180
16,455
16,096
16,129
27,209
Utilidad bruta
5,683
5,693
5,378
4,971
5,403
10,311
Venta, General y Administración
2,878
2,883
2,919
3,027
3,094
5,453
Investigación y Desarrollo
599
633
600
572
593
762
Gastos de Operación
3,378
3,383
3,596
3,735
3,566
6,132
Otras Ingresos (Gastos) No Operativos
9
9
--
--
--
--
Ingreso antes de impuestos
2,182
2,188
1,388
773
1,597
3,652
Gasto por Impuesto a la Renta
579
582
521
485
375
833
Ingreso Neto
1,264
1,264
471
-594
1,372
1,818
Crecimiento de la Utilidad Neta
168%
168%
-179%
-143%
-25%
7%
Acciones en Circulación (Diluidas)
573.01
564.28
563.23
563.23
561.26
558.15
Cambio de Acciones (YoY)
2%
0%
0%
0%
1%
0%
EPS (Diluido)
2.2
2.24
0.83
-1.05
2.44
3.25
Crecimiento de EPS
165%
170%
-179%
-143%
-25%
6%
Flujo de efectivo libre
--
--
1,492
3,286
2,281
3,031
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
25.05%
24.88%
24.63%
23.59%
25.09%
27.48%
Margen de operación
10.16%
10.09%
8.16%
5.86%
8.53%
11.13%
Margen de beneficio
5.57%
5.52%
2.15%
-2.81%
6.37%
4.84%
Margen de flujo de caja libre
--
--
6.83%
15.59%
10.59%
8.07%
EBITDA
--
--
2,986
2,714
4,810
6,846
Margen de EBITDA
--
--
13.67%
12.88%
22.33%
18.24%
D&A para EBITDA
--
--
1,204
1,478
2,973
2,667
EBIT
2,305
2,310
1,782
1,236
1,837
4,179
Margen de EBIT
10.16%
10.09%
8.16%
5.86%
8.53%
11.13%
Tasa de Impuesto Efectiva
26.53%
26.59%
37.53%
62.74%
23.48%
22.8%
Follow-Up Questions
Fresenius SE & Co KGaA 的關鍵財務報表是什麼?
根據最新的財務報表(Form-10K),Fresenius SE & Co KGaA 的總資產為 $0,淨ganancia為 $1,264
FSNUF 的關鍵財務比率是什麼?
Fresenius SE & Co KGaA 的流動比率為 0,淨利潤率為 5.52,每股銷售為 $40.53。
Fresenius SE & Co KGaA 的收入按細分市場或地理位置如何劃分?
El segmento de ingresos más grande es Fresenius SE & Co KGaA, con unos ingresos de Fresenius Kabi en el último informe de ganancias. En cuanto a la geografía, North America es el mercado principal para Fresenius SE & Co KGaA, con unos ingresos de 2,701,000,000.
Fresenius SE & Co KGaA 是否盈利?
sí,根據最新的財務報表,Fresenius SE & Co KGaA 的淨ganancia為 $1,264